Life expectancy and quality of life for those born with congenital heart disease (CHD) have
greatly improved over the past 3 decades. While representing a great advance for these …

Pulmonary arterial hypertension (PAH) is a common complication of congenital heart
disease (CHD), with most cases occurring in patients with congenital cardiac shunts. In …

Background—Advanced therapy (AT) for pulmonary arterial hypertension in the context of
congenital heart disease (Eisenmenger syndrome) improves pulmonary hemodynamics …

Pulmonary arterial hypertension related to congenital heart disease (PAH-CHD) is a
common type of pulmonary arterial hypertension (PAH). Despite this, little emphasis has …

Background The aging congenital heart disease (CHD) population is prone to develop a
variety of sequelae, including pulmonary arterial hypertension (PAH). Previous prevalence …

Background The objective of this prospective study was to assess the efficacy of exercise
training as add-on to medical therapy in patients with congenital heart disease associated …

Cardiac and pulmonary pathophysiologies are closely interdependent, which makes the
management of patients with congenital heart disease (CHD) all the more complex …

OBJECTIVES: The aim of the present study was to evaluate the safety, tolerability, clinical
and haemodynamic impact of add-on sildenafil in patients with congenital heart disease …

Pulmonary arterial hypertension (PAH) commonly arises in patients with congenital heart
disease (CHD). Greater numbers of patients with PAH associated with CHD (PAH-CHD) are …

Congenital heart disease (CHD), the most common inborn defect, affects approximately 1%
of all newborns worldwide. Advances in its diagnosis and treatment have led to a dramatic …